Build epidemiology-based revenue forecasts for business development and licensing deals — in hours, not weeks. No consultants. No waiting. Just a defensible model ready for your next deal.
Request a DemoBusiness development moves fast. Licensing opportunities open and close in weeks. But the forecasting process your team relies on hasn't kept up.
You're either rebuilding the same epidemiology model in Excel for every deal — or waiting 6 to 8 weeks and $50,000+ for an external consulting firm to deliver a report.
Neither option is acceptable when a decision needs to be made by Friday.
The pharmaceutical and biotech industry has world-class analytical talent. What it's been missing is a tool that matches the speed of a deal.
PharmaceuticalForecasting.com is a self-serve revenue modeling platform designed specifically for the pharmaceutical and biotech BD&L workflow.
You enter your molecule assumptions/parameters. We run the epidemiology-based model. You get a scenario-ready, audit-friendly forecast — the same day.
No consulting firm. No kick-off meeting. No 8-week timeline.
Built on the same patient-based methodology used by forecasting teams at the world's top pharmaceutical companies. Inputs your target indication's diagnosis rates, treatment rates, and market share assumptions to generate a 30-year revenue projection grounded in clinical reality — not guesswork.
Model your optimistic, base, and conservative cases simultaneously. Adjust peak share assumptions, time-to-peak, generic entry dates, and loss of exclusivity — and see the revenue impact in real time. Give your leadership team the range they need to make a confident licensing decision.
Capture the full commercial arc of an asset. Our S-curve adoption model reflects real-world drug uptake dynamics, and our generic erosion analysis accounts for the post-exclusivity revenue cliff every BD&L deal must price in.
Your forecasts live in your workflow, not ours. Import existing data from Excel, run your model, and export audit-ready outputs directly back to Excel. No locked-in platform. No proprietary format.
Save, load, and share forecast models with your commercial analytics team and leadership. Built-in audit trails mean every assumption is documented and defensible — from first draft to deal committee presentation.
Input your indication, target patient population, diagnosis and treatment rates, market share trajectory, and pricing assumptions.
Our platform calculates a 30-year revenue projection using a validated, patient-based epidemiology methodology. Adjust your S-curve adoption rate, peak share timing, and loss-of-exclusivity assumptions to model the full commercial lifecycle.
Download your forecast in Excel/Powerpoint. Share it with your team. Present it to your deal committee. Your assumptions are fully documented, your model is transparent, and your conclusion is ready to defend.
Schedule a 30-minute demo and see how PharmaceuticalForecasting.com can replace your Excel model — and your consulting dependency — for good.
Request a DemoNo commitment required. Built for pharma and biotech BD&L teams of all sizes.